Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy
Wei Wu(Huanggang Normal University), Chenqi Xu(Chinese Academy of Sciences), Xinyi Xu(Center for Excellence in Molecular Cell Science), Jie Sun(North Sichuan Medical University), Hengyu Zhu(Center for Excellence in Molecular Cell Science), Shuaixin Gao(Peking University), Enfu Hui(University of California San Diego), Nan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hua Li(First Bethune Hospital of Jilin University), Meng Li(Center for Excellence in Molecular Cell Science), Min Huang(Chinese Academy of Sciences), Haopeng Wang(Guangxi University), Qiuping Zhou(Center for Excellence in Molecular Cell Science), Ruirui Jing(First Affiliated Hospital Zhejiang University), Xing He(Sun Yat-sen University), Takeya Masubuchi(University of California San Diego), Catherine Chiulan Wong(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoshan Shi(Peking University)
Cited by 187
Related Papers
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
|Science|2017|1.7k
Immune checkpoint signaling and cancer immunotherapy
|Cell Research|2020|1.4k
Evaluation of cell-free DNA approaches for multi-cancer early detection
|Cancer Cell|2022|311
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
|Signal Transduction and Targeted Therapy|2023|289